Commonwealth Equity Services, LLC Emergent Bio Solutions Inc. Transaction History

Commonwealth Equity Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$33.11 - $55.01 $275,872 - $458,343	-8,332 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$50.07 - $66.05 $203,885 - $268,955	-4,072 Reduced 32.83%	8,332 $417,000
Q2 2021 Aug 11, 2021	SELL	$56.61 - $80.46 $45,684 - $64,931	-807 Reduced 6.11%	12,404 $781,000
Q1 2021 May 04, 2021	SELL	$86.23 - $125.19 $68,897 - $100,026	-799 Reduced 5.7%	13,211 $1.23 Million
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $194,283 - $273,547	2,454 Added 21.24%	14,010 $1.26 Million
Q3 2020 Nov 05, 2020	BUY	$81.91 - $134.94 $141,212 - $232,636	1,724 Added 17.53%	11,556 $1.19 Million
Q2 2020 Aug 12, 2020	BUY	$54.33 - $89.52 $62,751 - $103,395	1,155 Added 13.31%	9,832 $777,000
Q1 2020 May 11, 2020	BUY	$49.34 - $68.76 $38,238 - $53,289	775 Added 9.81%	8,677 $502,000
Q4 2019 Feb 05, 2020	BUY	$51.21 - $59.06 $404,661 - $466,692	7,902 New	7,902 $426,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $406M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.